Managers / Q1 2020 · view latest →
Lion Point Capital, LP
CIK 0001643354 · 375 PARK AVE, SUITE 2609, NEW YORK, NY, 10152 · 212-356-6200
Summary
Lion Point Capital, LP reported $379M in U.S.-listed holdings across 25 positions for Q1 2020.
Its largest position, CSIQ, represents 18.0% of the portfolio.
Compared with Q4 2019, the fund opened 8 new positions and exited 7.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 68.4% · $259M
- ETP · 24.0% · $91M
- Other · 7.5% · $29M
Quarter-over-Quarter Changes full breakdown →
vs Q4 2019 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| SWCHFSIERRA WIRELESS INC | NEW | +2.14M | 2.14M | +$12M | $12M |
| XOPSPDR SER TR | NEW | +316.3K | 316.3K | +$10M | $10M |
| KINIKSA PHARMACEUTICALS LTD | NEW | +495.7K | 495.7K | +$8M | $8M |
| BATLBATTALION OIL CORP | NEW | +1.43M | 1.43M | +$7M | $7M |
| OUTFRONT MEDIA INC | NEW | +300.0K | 300.0K | +$4M | $4M |
| LUMOS PHARMA INC | NEW | +407.2K | 407.2K | +$3M | $3M |
| LIBERTY GLOBAL PLC | NEW | +25.0K | 25.0K | +$392,000 | $392,000 |
| OVVOVINTIV INC | NEW | +90.1K | 90.1K | +$243,000 | $243,000 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2020
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | CSIQCANADIAN SOLAR INChistory → | COM | 17.99% | $68M | 4.29M |
| 2 | LSCCLATTICE SEMICONDUCTOR CORPhistory → | COM | 9.09% | $34M | 1.93M |
| 3 | DURECT CORP | COM | 7.97% | $30M | 19.49M |
| 4 | ACHCACADIA HEALTHCARE COMPANY INhistory → | COM | 7.55% | $29M | 1.56M |
| 5 | PRSPPERSPECTA INChistory → | COM | 4.33% | $16M | 900.0K |
| 6 | LIBERTY GLOBAL PLC | SHS CL A · SHS CL C | 4.24% | $16M | 975.0K |
| 7 | MARINUS PHARMACEUTICALS INC | COM | 3.41% | $13M | 6.37M |
| 8 | SWCHFSIERRA WIRELESS INChistory → | COM | 3.21% | $12M | 2.14M |
| 9 | ARCONIC INC | COM | 2.86% | $11M | 675.0K |
| 10 | AAALCOA CORPhistory → | COM | 2.76% | $10M | 1.70M |
| 11 | PDC ENERGY INC | COM | 2.40% | $9M | 1.47M |
| 12 | KINIKSA PHARMACEUTICALS LTD | COM CL A | 2.03% | $8M | 495.7K |
| 13 | BATLBATTALION OIL CORPhistory → | COM | 1.76% | $7M | 1.43M |
| 14 | COMSCORE INC | COM | 1.43% | $5M | 1.92M |
| 15 | CALLON PETE CO DEL | COM | 1.19% | $4M | 8.20M |
| 16 | OUTFRONT MEDIA INC | COM | 1.07% | $4M | 300.0K |
| 17 | LUMOS PHARMA INC | COM | 0.91% | $3M | 407.2K |
| 18 | EXTREXTREME NETWORKS INC | COM | 0.66% | $3M | 811.8K |
| 19 | LOGICBIO THERAPEUTICS INC | COM | 0.65% | $2M | 500.0K |
| 20 | OPES ACQUISITION CORP | UNIT 03/07/2023 | 0.21% | $799,000 | 83.4K |
| 21 | CIMAREX ENERGY CO | COM | 0.16% | $591,000 | 35.2K |
| 22 | OVVOVINTIV INC | COM | 0.06% | $243,000 | 90.1K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $17M | 35 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $19M | 39 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $18M | 27 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $15M | 19 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $16M | 21 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $19M | 19 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $45M | 25 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $55M | 27 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $179M | 32 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $200M | 30 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $224M | 31 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $221M | 30 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $243M | 31 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $703M | 32 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $454M | 41 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $878M | 40 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $431M | 35 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $373M | 33 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $533M | 38 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $579M | 34 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $550M | 30 | May 19, 2021 | RESTATEMENT | changes · EDGAR ↗ |
| Q4 2020 | $519M | 24 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $456M | 24 | Nov 16, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $412M | 24 | Aug 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $379M | 25 | May 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $1.1B | 26 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $897M | 26 | Nov 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $1.0B | 24 | Aug 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $1.1B | 24 | May 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $636M | 35 | Feb 14, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.